bi 691751
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01843972)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Leukotriene A-4 hydrolaseINHIBITOR
LTA4H inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 691751
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02175238 | Phase 1 | Jul 1, 2014 | Boehringer Ingelheim |
| NCT02148107 | Phase 1 | May 1, 2014 | Boehringer Ingelheim |
| NCT02057835 | Phase 1 | Mar 1, 2014 | Boehringer Ingelheim |
| NCT02044393 | Phase 1 | Jan 1, 2014 | Boehringer Ingelheim |
| NCT01843972 | Phase 1 | Apr 1, 2013 | Boehringer Ingelheim |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 5 | 5 | 1 | 2013 |
1 organizations
Page 1 / 1